SCHEMBL20127630

SCHEMBL20127630

CC1(C)c2ccccc2-c2ccc(-c3cccc(-c4c5ccccc5c(-c5ccc6oc7c(ccc8c9ccccc9oc87)c6c5)c5ccccc45)c3)cc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.39
PLA2G2A P14555 3/20 0.36
PLA2G4A P47712 3/20 0.36
PLA2G10 O15496 1/20 0.36
PRKDC P78527 2/20 0.35
PGR P06401 1/20 0.34
HSP90AA1 P07900 1/20 0.33
HSP90AB1 P08238 1/20 0.33
ALK Q9UM73 1/20 0.33
PDK2 Q15119 4/20 0.33
GGPS1 O95749 1/20 0.33
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
CYP2C19 P33261 1/20 0.32
PTGES2 Q9H7Z7 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.30
KDM4E B2RXH2 1/20 0.30
NPC1 O15118 1/20 0.30
ALDH1A1 P00352 1/20 0.30
MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20127607 0.96 ALOX5 (0.40) ALOX5PRKDCPGRHSP90AA1HSP90AB1
SCHEMBL20127621 0.94 ALOX5 (0.38) ALOX5PLA2G2APLA2G4APRKDCPGR
SCHEMBL25052860 0.93 ALOX5 (0.41) ALOX5PLA2G2APLA2G4APLA2G10PRKDC
SCHEMBL25052528 0.93 ALOX5 (0.41) ALOX5PLA2G2APLA2G4APLA2G10PRKDC
SCHEMBL25052370 0.91 ALOX5 (0.37) ALOX5PLA2G2APLA2G4APLA2G10PRKDC
SCHEMBL25052924 0.91 ALOX5 (0.37) ALOX5PLA2G2APLA2G4APLA2G10PRKDC
SCHEMBL16067516 0.91 CYP1A1 (0.33) ALOX5PLA2G2APLA2G4APLA2G10PRKDC
SCHEMBL10442776 0.91 ALOX5 (0.45) ALOX5PLA2G2APLA2G4APLA2G10PRKDC
SCHEMBL13488111 0.90 ALOX5 (0.43) ALOX5PRKDCPGRPDK2GGPS1
SCHEMBL18272692 0.90 ALOX5 (0.50) ALOX5PLA2G2APLA2G4APRKDCPGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE RER1, NR0B1, NR2E1 ALOX5 4115/4885PLA2G2A 2960/4885PLA2G4A 3780/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.